Artículos de revistas
Neurotransmitter GABA Activates Muscle but not a7 Nicotinic Receptors
Fecha
2015-03Registro en:
Dionisio, Leonardo Raul; Bergé, Ignacio; Bravo, Matías; Esandi, María del Carmen; Bouzat, Cecilia Beatriz; Neurotransmitter GABA Activates Muscle but not a7 Nicotinic Receptors; American Society For Pharmacology And Experimental Therapeutics; Molecular Pharmacology; 87; 3-2015; 391-400
0026-895X
Autor
Dionisio, Leonardo Raul
Bergé, Ignacio
Bravo, Matías
Esandi, María del Carmen
Bouzat, Cecilia Beatriz
Resumen
Cys-loop receptors are neurotransmitter-activated ion channels involved in synaptic and extrasynaptic transmission in the brain and are also present in non-neuronal cells. As GABAA and nicotinic receptors (nAChR) belong to this family, we explored by macroscopic and single-channel recordings whether the inhibitory neurotransmitter GABA has the ability to activate excitatory nAChRs. GABA differentially activates nAChR subtypes. It activates muscle nAChRs, with maximal peak currents of about 10% of those elicited by acetylcholine (ACh) and 15- fold higher EC50 with respect to ACh. At the single-channel level, the weak agonism is revealed by the requirement of 20-fold higher concentration of GABA for detectable channel openings, a major population of brief openings, and absence of clusters of openings when compared with ACh. Mutations at key residues of the principal binding-site face of muscle nAChRs (aY190 and aG153) affect GABA activation similarly as ACh activation, whereas a mutation at the complementary face (EG57) shows a selective effect for GABA. Studies with subunit-lacking receptors show that GABA can activate muscle nAChRs through the a/d interface. Interestingly, single-channel activity elicited by GABA is similar to that elicited by ACh in gain-of-function nAChR mutants associated to congenital myasthenic syndromes, which could be important in the progression of the disorders due to steady exposure to serum GABA. In contrast, GABA cannot elicit single-channel or macroscopic currents of a7 or the chimeric a7-serotonin-type 3 receptor, a feature important for preserving an adequate excitatory/inhibitory balance in the brain as well as for avoiding activation of nonneuronal receptors by serum GABA.